SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS
PCT No. PCT/US95/02420 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/24385 PCT Pub. Date Sep. 14, 1995This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: This invention also provides...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BHISETTI, GOVINDA, RAO TUNG, ROGER, DENNIS SALITURO, FRANCESCO, GERALD DEININGER, DAVID, D MURCKO, MARK, ANDREW NOVAK, PERRY, MICHAEL |
| description | PCT No. PCT/US95/02420 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/24385 PCT Pub. Date Sep. 14, 1995This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: This invention also provides pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also provides methods for inhibition aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0749421A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0749421A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0749421A13</originalsourceid><addsrcrecordid>eNrjZLAIDvUJ8PD3c_T1dHFVcHEN8gxzDPEMcw1WcAShAMegkEgfhYAg_xBXx2BXBU8_D08nzxD_oGAeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBgbmJpYmToaGhMhBIATbQojg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS</title><source>esp@cenet</source><creator>BHISETTI, GOVINDA, RAO ; TUNG, ROGER, DENNIS ; SALITURO, FRANCESCO, GERALD ; DEININGER, DAVID, D ; MURCKO, MARK, ANDREW ; NOVAK, PERRY, MICHAEL</creator><creatorcontrib>BHISETTI, GOVINDA, RAO ; TUNG, ROGER, DENNIS ; SALITURO, FRANCESCO, GERALD ; DEININGER, DAVID, D ; MURCKO, MARK, ANDREW ; NOVAK, PERRY, MICHAEL</creatorcontrib><description>PCT No. PCT/US95/02420 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/24385 PCT Pub. Date Sep. 14, 1995This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: This invention also provides pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also provides methods for inhibition aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention.</description><edition>6</edition><language>eng ; fre ; ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961227&DB=EPODOC&CC=EP&NR=0749421A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961227&DB=EPODOC&CC=EP&NR=0749421A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BHISETTI, GOVINDA, RAO</creatorcontrib><creatorcontrib>TUNG, ROGER, DENNIS</creatorcontrib><creatorcontrib>SALITURO, FRANCESCO, GERALD</creatorcontrib><creatorcontrib>DEININGER, DAVID, D</creatorcontrib><creatorcontrib>MURCKO, MARK, ANDREW</creatorcontrib><creatorcontrib>NOVAK, PERRY, MICHAEL</creatorcontrib><title>SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS</title><description>PCT No. PCT/US95/02420 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/24385 PCT Pub. Date Sep. 14, 1995This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: This invention also provides pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also provides methods for inhibition aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAIDvUJ8PD3c_T1dHFVcHEN8gxzDPEMcw1WcAShAMegkEgfhYAg_xBXx2BXBU8_D08nzxD_oGAeBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBgbmJpYmToaGhMhBIATbQojg</recordid><startdate>19961227</startdate><enddate>19961227</enddate><creator>BHISETTI, GOVINDA, RAO</creator><creator>TUNG, ROGER, DENNIS</creator><creator>SALITURO, FRANCESCO, GERALD</creator><creator>DEININGER, DAVID, D</creator><creator>MURCKO, MARK, ANDREW</creator><creator>NOVAK, PERRY, MICHAEL</creator><scope>EVB</scope></search><sort><creationdate>19961227</creationdate><title>SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS</title><author>BHISETTI, GOVINDA, RAO ; TUNG, ROGER, DENNIS ; SALITURO, FRANCESCO, GERALD ; DEININGER, DAVID, D ; MURCKO, MARK, ANDREW ; NOVAK, PERRY, MICHAEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0749421A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>1996</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BHISETTI, GOVINDA, RAO</creatorcontrib><creatorcontrib>TUNG, ROGER, DENNIS</creatorcontrib><creatorcontrib>SALITURO, FRANCESCO, GERALD</creatorcontrib><creatorcontrib>DEININGER, DAVID, D</creatorcontrib><creatorcontrib>MURCKO, MARK, ANDREW</creatorcontrib><creatorcontrib>NOVAK, PERRY, MICHAEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BHISETTI, GOVINDA, RAO</au><au>TUNG, ROGER, DENNIS</au><au>SALITURO, FRANCESCO, GERALD</au><au>DEININGER, DAVID, D</au><au>MURCKO, MARK, ANDREW</au><au>NOVAK, PERRY, MICHAEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS</title><date>1996-12-27</date><risdate>1996</risdate><abstract>PCT No. PCT/US95/02420 Sec. 371 Date Apr. 1, 1996 Sec. 102(e) Date Apr. 1, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/24385 PCT Pub. Date Sep. 14, 1995This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: This invention also provides pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also provides methods for inhibition aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP0749421A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SULPHONAMIDE DERIVATIVES AS ASPARTYL PROTEASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BHISETTI,%20GOVINDA,%20RAO&rft.date=1996-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0749421A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |